|
Recent Updates on Diagnosis, Treatment and Challenges of COVID-19: A Review
|
|
| Author:
|
ANKIT SHARMA, AVIJIT MAZUMDER, SAUMYA DAS, ANAMIKA SHARMA, SUNITI CHAND
|
| Abstract:
|
A novel COVID-19, designated as extreme Acute Respiratory Syndrome COVID-19 2 (SARS-CoV-2), was first
identified in Wuhan, China in December 2019, triggering COVID-19, a highly infectious disease. As of August
26, 2020, COVID-19 has now spread globally to become a global pandemic affecting more than 24 million
people, taking the lives of more than 800,000 people worldwide. For certain people, COVID-19 is
asymptomatic and it can cause symptoms ranging from flu-like to acute respiratory distress syndrome (ARDS),
pneumonia and death for others. While an effective vaccine to protect against COVID-19 is supposed to be
available, the world currently relies on social distancing and hygiene initiatives and repurposed medicines.
Different body systems have been shown to have significant adverse effects: the immune system (including, but
not limited to, Guillain-Barré syndrome and pediatric multisystem inflammatory syndrome), the respiratory
system (lung fibrosis and pulmonary thromboembolism), the cardiovascular system (cardiomyopathy and
coagulopathy), the nervous system (sensory dysfunction and stroke) and the skin and gastrointestinal system.
Mental wellbeing was also found to be adversely affected in COVID-19 patients. It is possible that the cost of
caring for survivors of COVID-19 is high. The COVID-19 pandemic poses an unprecedented global challenge
that has been addressed by the rapid development of pharmacological research and clinical trials with a
remarkable response. As are the possible therapeutic agents, the infection rates of COVID-19 are constantly
evolving. Management is currently focused on case identification and control, prevention of infections, and
compassionate treatment. In this review, the recent updates of diagnosis, treatment and challenges of COVID-
19 will be discussed.
|
| Keyword:
|
COVID Respiratory Syndrome, pneumonia, pandemic, diagnosis, adverse effects, management.
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2021.13.02.187
|
| Download:
|
Request For Article
|
|
|